Ple Na es we dJ oo u nr no at l ao df jCu hs et mm i as tr rgy ins
Page 4 of 6
COMMUNICATION
Journal Name
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
3
3
3
3
3
3
3
3
3
3
4
4
4
4
4
4
4
4
4
4
5
5
5
5
5
5
5
5
5
5
6
[
funding this project. B. R. thanks UGDCOI,: 1N0.e1w039D/Ce8lNhJi,06f2o9r9Da
Senior Research Fellowship.
Conflicts of interest
The authors confirm that this article content has no conflict of
interest.
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
1
2
3
4
5
6
7
8
9
0
Notes and references
1
.
(a) K. C. Nicolaou, T. Montagnon and S. A. Snyder,
Chem. Commun., 2003, 551; (b) D. J. Ramon and M.
Yus, Angew. Chem. Int. Ed., 2005, 44, 1602; (c) L. F.
Tietze, Chem. Rev., 1996, 96, 115; (d) L. F. Tietze and
F. Haunert, Stimulating Concepts in Chemistry (eds F.
Vogtle, J. F. Stoddart, M. Shibasaki) 39-64 (Wiley-
VCH, Weinheim, 2000); (e) L. F. Tietze and A. Modi,
Med. Res. Rev., 2000, 20, 304: (e) N. T. Patil, V. S.
Shinde and B. Gajula, Org. Biomol. Chem., 2012, 10,
211.
(a) A. T. Balaban, D. C. Oniciu and A. R. Katritzky,
Chem. Rev., 2004, 104, 2777; (b) L. Zhang, X. M. Peng,
G. L. V. Damu, R. X. Geng and C. H. Zhou, Med. Res.
Rev., 2014, 34, 340.
Fig. 2 X-ray crystal structure of 7q (ORTEP diagram). Thermal
ellipsoids are drawn at the 50% probability level.
Indazole 3 results in the formation of the key intermediate triazol-
2
.
1
-yl)phenyl)-2H-indazole (6). In the second catalytic cycle,
electrophilic palladiation occurs at C3-position of indazole that
results in the formation of intermediate D. Further electrophilic
palladation of trizole occurs to form seven-membered palladacycle
intermediate E, which on reductive elimination generates the
indazole fused triazolo[5,1-c]quinoxalines (7) together with Pd(0).
Finally, palladium acetate was regenerated from Pd(0) under
oxidant to complete the catalytic cycle.
3. (a) A. R. Katritzky, D. O. Tymoshenko, D. Monteux, V.
Vvedensky, G. Nikonov, C. B. Cooper, and M.
Deshpande, J. Org. Chem., 2000, 65, 8059; (b) E. Arzel,
P. Rocca, P. Grellier, M. Labaeïd, F. Frappier, F.
Guéritte, C. Gaspard, F. Marsais, A. Godard and G.
Quéguiner, J. Med. Chem., 2001, 44, 949; (c) A. Lauria,
C. Patella, G. Dattolo and A. M. Almerico, J. Med.
Chem., 2008, 51, 2037.
4. (a) A. R. Katrizky, C. W. Rees, E. F. V. Scriven,
Comprehensive Heterocyclic Chemistry (Eds.: A. R.
Katrizky, C. W. Rees), PergamonPress, Oxford, UK,
1996, vol. 1–8; (b) E. Vitaku, D. T. Smith and J. T.
Njardarson, J. Med. Chem., 2014, 57, 10257; (c) T.
Laird, Org. Process Res. Dev. 2006, 10, 851; (d) G.
Zheng, L. P. Dwoskin, A. G. Deaciuc, J. Zhu, M. D.
Jones and P. A. Crooks, Bioorg. Med. Chem., 2005, 13,
3899.
O
H
N3
H
Cu
Cu
N
1
I
N
N
N
B
N
Ph
NH2
N
C
2
Ph
I
I
R
4
Cu(I)
+
N
NaN3 5
N
N
N
N
N
N
Pd(OAc)2
3
N
A
N
Pd(II)
Oxidant
5. (a) A. H. Bansode, A. C. Shaikh, R. D. Kavthe, S.
Thorat, R. G. Gonnade and N. T. Patil, Chem. – Eur. J.,
Ph
N
N
6
2
015, 21, 2319; (b) N. T. Patil, V. S. Shinde and B.
Sridhar, Angew. Chem., Int. Ed., 2013, 52, 2251.
S. V. Keisner and S. R. Shah, Drugs 2011, 71, 443.
N
Pd(0
)
N
6
.
(
II)Pd
N
7
Ph
D
N
N
N
7. P. Jones, S. Altamura, J. Boueres, F. Ferrigno, M. Fonsi,
C. Giomini, S. Lamartina, E. Monteagudo, J. M.
Ontoria, M. V. Orsale, M. C. Palumbi, S. Pesci, G.
Roscilli, R. Scarpelli, C. Schultz-Fademrecht, C.
Toniatti and M. Rowley, J. Med. Chem., 2009, 52, 7170.
8. R. Halim, M. Harding, R. Hufton, C. J. Morton, S.
Jahangiri, B. R. Pool, T. P. Jeynes, A. G. Draffan,M. J.
N
Pd
Ph
N
N
N
E
Scheme 3 Plausible mechanism.
Lilly
and
B.
Frey,
PCT
Int.
In conclusion, we have demonstrated a facile and efficient route
for the synthesis of diverse indazole fused triazolo[5,1-
c]quinoxalines through one-pot sequential cascade reaction of o-
azido aldehyde, o-iodoaniline, phenylacetylene and sodium azide.
The reaction proceeds via 2H-indazole formation, azide–alkyne
cycloaddition followed by C−N coupling and intramolecular cross
dehydrogenative C−C coupling. Overall, we have reported
synthesis of privileged fused heterocyclic compounds from simple
starting meterials.
Appl,WO2012051659A120120426, 2012.
9. (a) D. Catarzi, V. Colotta, F. Varano, O. Lenzi, G.
Pharm. Chem. Life Sci., 2006, 339, 564; (d) H. C. Shen,
F.-X. Ding, Q. Deng, L. C. Wilsie, M. L. Krsmanovic,
A. K. Taggart, E. Carballo-Jane, N. Ren, T.-Q. Cai, T. -
J. Wu, K. K. Wu, K. Cheng, Q. Chen, M. S. Wolff, X.
Tong, T. G. Holt, M. G. Waters, M. L. Hammond, J. R.
KSK thanks the University Grants Commission (UGC), New
Delhi, for a faculty position under FRP. We also thank CSIR
4
| J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins